STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[144] The Ensign Group, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144
Rhea-AI Filing Summary

The Ensign Group, Inc. (ENSG) filed Form 144 disclosing a planned sale of 425 common shares through Fidelity Brokerage Services LLC, expected on or after 31 Jul 2025. The shares have an estimated aggregate market value of $63,422.75 and represent an immaterial ~0.0007 % of the company’s 57.7 million shares outstanding.

The securities were originally received as restricted-stock vesting awards on 15 Jan 2021 (260 sh) and 15 Jul 2021 (165 sh) as compensation from the issuer. The filer reports no sales in the prior three months. Given the small size and routine nature of the transaction, the notice is unlikely to have a meaningful impact on ENSG’s share price but does signal a minor insider disposition.

Positive
  • None.
Negative
  • Insider intends to sell shares, which some investors may interpret as a modest confidence signal, though the volume is trivial.

Insights

TL;DR: Very small Form 144; immaterial to valuation or liquidity.

The 425-share sale equates to less than one-tenth of one basis point of shares outstanding and only about one day’s average trading volume. Such routine insider liquidity events rarely influence market supply-demand dynamics or signal strategic shifts. No accelerated selling trend is evident, as the filer reports zero sales in the past quarter. I view the disclosure as neutral for investors.

TL;DR: Standard compliance filing; negligible governance concern.

The shares stem from standard equity compensation vesting, and the Form 144 affirms the insider’s representation of possessing no undisclosed material information. Absence of a 10b5-1 date suggests discretionary timing, but the volume is so small that governance risk remains minimal. Overall impact on perception of insider confidence is insignificant.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

How many ENSG shares are being sold under this Form 144?

The filing covers 425 common shares of The Ensign Group, Inc.

What is the value of the planned ENSG share sale?

The aggregate market value listed is $63,422.75.

When is the approximate sale date for the ENSG shares?

The filer indicates an approximate sale date of July 31, 2025.

How significant is the sale relative to ENSG’s shares outstanding?

The 425 shares represent about 0.0007 % of the company’s 57.7 million shares outstanding.

Were these ENSG shares purchased or received as compensation?

They were restricted-stock vesting awards received on 15 Jan 2021 and 15 Jul 2021 as compensation from the issuer.
Ensign Group Inc

NASDAQ:ENSG

ENSG Rankings

ENSG Latest News

ENSG Latest SEC Filings

ENSG Stock Data

10.39B
55.92M
3.43%
94.65%
3.17%
Medical Care Facilities
Services-skilled Nursing Care Facilities
Link
United States
SAN JUAN CAPISTRANO